Please login to the form below

Not currently logged in
Email:
Password:

ASH meeting

This page shows the latest ASH meeting news and features for those working in and with pharma, biotech and healthcare.

AbbVie, Roche get FDA OK for broader use of Venclexta

AbbVie, Roche get FDA OK for broader use of Venclexta

of Haematology (ASH) meeting. ... The trial was the first to test new a new CLL agent against standard chemo-immunotherapy and – according to investigators at ASH – suggested that Venclexta should replace chemotherapy in relapsed or

Latest news

More from news
Approximately 4 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2016 Deal Watch November 2016

    This is despite some positive news for Juno released at the recent ASH meeting that another of its CAR T cell therapeutics, JCAR017, showed a 60% complete response in patients with ... As Juno wrestles with bad publicity and a depressed share price,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics